$EGAN
eGain Corp Stock $egan

$egan Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000155837024012767 Filed on September 12, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024
Revenue	$21.80M	$22.46M	$92.80M
YoY Change	-9.83%	-8.82%	-5.31%
Cost Of Revenue	$6.666M	$6.906M	$27.59M
YoY Change	-2.52%	3.29%	1.01%
Gross Profit	$15.13M	$15.56M	$65.21M
YoY Change	-12.72%	-13.33%	-7.76%
Gross Profit Margin	69.42%	69.25%	70.27%
Selling, General & Admin	$7.203M	$7.685M	$32.61M
YoY Change	-22.47%	-14.99%	-22.36%
% of Gross Profit	47.6%	49.4%	50.01%
Research & Development	$7.421M	$6.679M	$26.63M
YoY Change	11.9%	1.95%	-2.47%
% of Gross Profit	49.04%	42.94%	40.83%
Depreciation & Amortization		$91.00K	$387.0K
YoY Change		-17.27%	-21.02%
% of Gross Profit		0.58%	0.59%
Operating Expenses	$14.62M	$14.36M	$59.24M
YoY Change	-8.15%	-7.87%	-14.53%
Operating Profit	$509.0K	$1.192M	$5.971M
YoY Change	-64.05%	-49.45%	329.88%
Interest Expense	$771.0K	$865.0K	$3.798M
YoY Change	-18.76%	12.63%	58.18%
% of Operating Profit	151.47%	72.57%	63.61%
Other Income/Expense, Net	-$140.0K	-$38.00K	-$51.00K
YoY Change	-122.95%	-91.63%	-88.25%
Pretax Income	$1.140M	$2.019M	$9.718M
YoY Change	-61.68%	-24.44%	189.57%
Income Tax	$488.0K	$513.0K	$1.938M
% Of Pretax Income	42.81%	25.41%	19.94%
Net Earnings	$652.0K	$1.506M	$7.780M
YoY Change	-74.88%	-42.1%	268.9%
Net Earnings / Revenue	2.99%	6.7%	8.38%
Basic Earnings Per Share	$0.02	$0.05	$0.25
Diluted Earnings Per Share	$0.02	$0.05	$0.25
COMMON SHARES
Basic Shares Outstanding	28.51M	29.83M	30.84M
Diluted Shares Outstanding	29.29M		31.47M

Balance Sheet

Concept	2024 Q3	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments		$70.00M	$70.00M
YoY Change		-4.37%	-4.37%
Cash & Equivalents	$67.21M	$70.00M	$70.00M
Short-Term Investments
Other Short-Term Assets	$857.0K	$5.390M	$5.390M
YoY Change	-34.28%	325.08%	6.56%
Inventory
Prepaid Expenses	$2.331M	$2.915M
Receivables	$23.05M	$31.73M	$31.73M
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$94.72M	$107.1M	$107.1M
YoY Change	-8.36%	-2.46%	-2.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$461.0K	$4.252M	$4.252M
YoY Change	-16.33%	571.72%	23.97%
Goodwill	$13.19M	$13.19M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.247M	$3.290M	$3.290M
YoY Change	-12.61%	142.8%	-10.43%
Total Long-Term Assets	$20.20M	$20.73M	$20.73M
YoY Change	3.06%	2.16%	2.16%
TOTAL ASSETS
Total Short-Term Assets	$94.72M	$107.1M	$107.1M
Total Long-Term Assets	$20.20M	$20.73M	$20.73M
Total Assets	$114.9M	$127.9M	$127.9M
YoY Change	-6.54%	-1.74%	-1.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.906M	$2.725M	$2.725M
YoY Change	123.45%	33.32%	33.32%
Accrued Expenses	$2.513M	$13.90M	$13.90M
YoY Change	-42.96%	158.01%	-0.12%
Deferred Revenue	$41.03M	$45.99M
YoY Change	-2.21%	-3.71%
Short-Term Debt		$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$52.91M	$62.61M	$62.61M
YoY Change	-1.73%	-1.74%	-1.74%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$938.0K	$6.743M	$6.743M
YoY Change	12.61%	706.58%	43.5%
Total Long-Term Liabilities	$938.0K	$6.743M	$6.743M
YoY Change	12.61%	706.58%	43.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$52.91M	$62.61M	$62.61M
Total Long-Term Liabilities	$938.0K	$6.743M	$6.743M
Total Liabilities	$59.17M	$69.36M	$69.36M
YoY Change	0.8%	1.37%	1.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$323.0M	-$323.7M
YoY Change	-1.77%	-2.35%
Common Stock	$408.2M	$407.4M
YoY Change	1.47%	1.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$55.75M	$58.50M	$58.50M
YoY Change
Total Liabilities & Shareholders Equity	$114.9M	$127.9M	$127.9M
YoY Change	-6.54%	-1.74%	-1.74%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024
OPERATING ACTIVITIES
Net Income	$652.0K	$1.506M	$7.780M
YoY Change	-74.88%	-42.1%	268.9%
Depreciation, Depletion And Amortization		$91.00K	$387.0K
YoY Change		-17.27%	-21.02%
Cash From Operating Activities	$954.0K	-$5.120M	$12.45M
YoY Change	-88.27%	14.8%	169.51%
INVESTING ACTIVITIES
Capital Expenditures	$109.0K	$49.00K	$198.0K
YoY Change	240.63%	-30.0%	-31.25%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$109.0K	-$49.00K	-$198.0K
YoY Change	240.63%	-30.0%	-31.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.422M	-7.929M	-15.39M
YoY Change	821.25%	93.86%	277.32%
NET CHANGE
Cash From Operating Activities	954.0K	-5.120M	12.45M
Cash From Investing Activities	-109.0K	-49.00K	-198.0K
Cash From Financing Activities	-4.422M	-7.929M	-15.39M
Net Change In Cash	-2.798M	-13.10M	-3.197M
YoY Change	-142.23%	51.95%	-410.99%
FREE CASH FLOW
Cash From Operating Activities	$954.0K	-$5.120M	$12.45M
Capital Expenditures	$109.0K	$49.00K	$198.0K
Free Cash Flow	$845.0K	-$5.169M	$12.26M
YoY Change	-89.57%	14.11%	182.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001066194
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-35314
CY2024	dei	Entity Registrant Name EntityRegistrantName	eGain Corporation
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0466366
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	1252 Borregas Avenue
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Sunnyvale
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94089
CY2024	dei	City Area Code CityAreaCode	408
CY2024	dei	Local Phone Number LocalPhoneNumber	636-4500
CY2024	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2024	dei	Trading Symbol TradingSymbol	EGAN
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	176500000
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28511553
CY2024	dei	Auditor Firm AuditorFirmId	207
CY2024	dei	Auditor Name AuditorName	BPM LLP
CY2024	dei	Auditor Location AuditorLocation	San Jose, California
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	70003000
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	73201000
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8000
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7000
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	59000
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	237000
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31731000
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31569000
CY2024Q2	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1272000
CY2023Q2	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1317000
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2915000
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2466000
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1195000
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	1268000
CY2024Q2	us-gaap	Assets Current AssetsCurrent	107124000
CY2023Q2	us-gaap	Assets Current AssetsCurrent	109828000
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	441000
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	633000
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3811000
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2797000
CY2024Q2	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	1779000
CY2023Q2	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	2318000
CY2024Q2	us-gaap	Goodwill Goodwill	13186000
CY2023Q2	us-gaap	Goodwill Goodwill	13186000
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1511000
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1355000
CY2024Q2	us-gaap	Assets Assets	127852000
CY2023Q2	us-gaap	Assets Assets	130117000
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2725000
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2044000
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7642000
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7697000
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5078000
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5387000
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1179000
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	832000
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	45989000
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	47762000
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	62613000
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	63722000
CY2024Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	3280000
CY2023Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2101000
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2592000
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1762000
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	871000
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	836000
CY2024Q2	us-gaap	Liabilities Liabilities	69356000
CY2023Q2	us-gaap	Liabilities Liabilities	68421000
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32698000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32268000
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29160000
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31482000
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	33000
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	32000
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	407416000
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	401087000
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3538000
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	786000
CY2024Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	23031000
CY2023Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	5763000
CY2024Q2	egan	Notes Receivable From Stockholders NotesReceivableFromStockholders	21000
CY2023Q2	egan	Notes Receivable From Stockholders NotesReceivableFromStockholders	97000
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2240000
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2122000
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-323661000
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-331441000
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	58496000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	61696000
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	127852000
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	130117000
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	92803000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98011000
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	27592000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	27315000
CY2024	us-gaap	Gross Profit GrossProfit	65211000
CY2023	us-gaap	Gross Profit GrossProfit	70696000
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26626000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	27300000
CY2024	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	22115000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	31707000
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10499000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10300000
CY2024	us-gaap	Operating Expenses OperatingExpenses	59240000
CY2023	us-gaap	Operating Expenses OperatingExpenses	69307000
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	5971000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	1389000
CY2024	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	3798000
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	2401000
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-51000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-434000
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9718000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3356000
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1938000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1247000
CY2024	us-gaap	Net Income Loss NetIncomeLoss	7780000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2109000
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30840000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31959000
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31468000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32799000
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4529000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6246000
CY2024	us-gaap	Net Income Loss NetIncomeLoss	7780000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2109000
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-118000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	565000
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7662000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2674000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	56857000
CY2023	egan	Paid In Kind Interest On Stockholder Loan PaidInKindInterestOnStockholderLoan	-2000
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	610000
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1074000
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	5763000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6246000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	565000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2109000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	61696000
CY2024	egan	Paid In Kind Interest On Stockholder Loan PaidInKindInterestOnStockholderLoan	-1000
CY2024	us-gaap	Repayments Of Debt RepaymentsOfDebt	77000
CY2024	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	862000
CY2024	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	939000
CY2024	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	17268000
CY2024	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4529000
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-118000
CY2024	us-gaap	Net Income Loss NetIncomeLoss	7780000
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	58496000
CY2024	us-gaap	Profit Loss ProfitLoss	7780000
CY2023	us-gaap	Profit Loss ProfitLoss	2109000
CY2024	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	1499000
CY2023	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	1529000
CY2024	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1098000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1142000
CY2024	egan	Depreciation And Amortization Of Capital Lease Assets DepreciationAndAmortizationOfCapitalLeaseAssets	387000
CY2023	egan	Depreciation And Amortization Of Capital Lease Assets DepreciationAndAmortizationOfCapitalLeaseAssets	490000
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	93000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	260000
CY2024	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-91000
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	584000
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	4529000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	6246000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	9000
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	261000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4508000
CY2024	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	917000
CY2023	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	462000
CY2024	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	453000
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-164000
CY2024	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-67000
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	384000
CY2024	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	317000
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-71000
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	682000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	326000
CY2024	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-46000
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1068000
CY2024	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-306000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	405000
CY2024	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-578000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-60000
CY2024	egan	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-936000
CY2023	egan	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-1075000
CY2024	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	42000
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	29000
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12454000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4621000
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	198000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	288000
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-198000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-288000
CY2024	egan	Interest On Notes Receivable Due From Stockholders Financing Activities InterestOnNotesReceivableDueFromStockholdersFinancingActivities	1000
CY2024	egan	Proceeds From Repayment Of Notes Receivable Due From Stockholders ProceedsFromRepaymentOfNotesReceivableDueFromStockholders	77000
CY2024	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	862000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	610000
CY2024	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	939000
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1074000
CY2024	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	17268000
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5763000
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15391000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4079000
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-62000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	774000
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3197000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1028000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73208000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72180000
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70011000
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73208000
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1805000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1701000
CY2024	egan	Operating Lease Operating Lease Liability Increase Decrease Due To Lease Modification OperatingLeaseOperatingLeaseLiabilityIncreaseDecreaseDueToLeaseModification	2141000
CY2023	egan	Operating Lease Operating Lease Liability Increase Decrease Due To Lease Modification OperatingLeaseOperatingLeaseLiabilityIncreaseDecreaseDueToLeaseModification	91000
CY2024	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Organization and Nature of Business </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">eGain Corporation (eGain, the Company, our, we or us) automates customer engagement with an innovative knowledge hub, powered by conversational artificial intelligence (AI) and analytics. We sell mostly to large enterprises across financial services, telecommunications, retail, government, healthcare, and utilities seeking to better serve customers at scale while coping with content silos, process complexity, and regulatory compliance. With our mantra of <b style="font-weight:bold;">AX + BX + CX = DX™</b>, we guide clients to effortless digital experience (DX) by holistically optimizing agent experience (AX), business experience (BX) and customer experience (CX). Leading brands use eGain’s cloud software to improve customer satisfaction, empower agents, reduce service cost, and boost sales. We are headquartered in the United States. We also operate in the United Kingdom and India.</p>
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Use of Estimates </b><span style="font-size:11pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;font-weight:bold;visibility:hidden;"></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The estimates are based upon information available as of the date of the consolidated financial statements. Actual results could differ from those estimates. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">We evaluate our significant estimates, including those related to revenue recognition, provision for credit losses, valuation of stock-based compensation, valuation of long-lived assets, valuation of deferred tax assets, and litigation, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We refer to accounting estimates of this type as “critical accounting estimates.” </p>
CY2024	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-98000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-470000
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><b style="font-size:11pt;font-weight:bold;">Concentration of Credit Risk </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Financial instruments that subject us to concentrations of credit risk consist principally of cash and cash equivalents and trade accounts receivable. Cash and cash equivalents are deposited with high credit quality institutions. We are exposed to credit risk in the event of default by these institutions to the extent of the amount recorded on the consolidated balance sheets. We invest excess cash primarily in money market funds, which are highly liquid securities that bear minimal risk. In addition, we have investment policies and procedures that are reviewed periodically to minimize credit risk. Our cash, cash equivalents and restricted cash were $70.0 million as of June 30, 2024 and exceeded the FDIC (Federal Deposit Insurance Corporation) limits. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Our customer base extends across many different industries and geographic regions. Revenue is allocated to individual countries and geographic region by customer, based on where the product is shipped to and location of services performed. One customer, who is also a partner, accounted for 18% and 20% of total revenue for the years ended June 30, 2024 and 2023, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">We perform ongoing credit evaluations of our customers with outstanding receivables and generally do not require collateral. In addition, we established a provision for credit losses based upon factors surrounding the credit risk of customers, historical trends and other information. Four partners and customers accounted for a range of 12% to 22% of accounts receivable as of June 30, 2024. A set of different three partners and customers accounted for a range of 18% to 22% of accounts receivable as of June 30, 2023. </p>
CY2024Q2	egan	Cash Cash Equivalents And Restricted Cash CashCashEquivalentsAndRestrictedCash	70000000.0
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31700000
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31600000
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	49300000
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	49900000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2024	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2024	egan	Contract Cost Capitalized During Period ContractCostCapitalizedDuringPeriod	917000
CY2023	egan	Contract Cost Capitalized During Period ContractCostCapitalizedDuringPeriod	462000
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1500000
CY2024	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1500000
CY2024Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	3100000
CY2023Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	3600000
CY2024	us-gaap	Advertising Expense AdvertisingExpense	180000
CY2023	us-gaap	Advertising Expense AdvertisingExpense	686000
CY2024	us-gaap	Net Income Loss NetIncomeLoss	7780000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2109000
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30840000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31959000
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31468000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32799000
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2024	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	92803000
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	5971000
CY2024Q2	us-gaap	Noncurrent Assets NoncurrentAssets	441000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98011000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	1389000
CY2023Q2	us-gaap	Noncurrent Assets NoncurrentAssets	633000
CY2024	egan	Number Of Revenue Categories NumberOfRevenueCategories	2
CY2024	egan	Revenue Payment Term Minimum RevenuePaymentTermMinimum	P30D
CY2024	egan	Revenue Payment Term Maximum RevenuePaymentTermMaximum	P45D
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5062000
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5504000
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4621000
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4871000
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	441000
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	633000
CY2024	egan	Depreciation And Amortization Of Capital Lease Assets DepreciationAndAmortizationOfCapitalLeaseAssets	387000
CY2023	egan	Depreciation And Amortization Of Capital Lease Assets DepreciationAndAmortizationOfCapitalLeaseAssets	490000
CY2024	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	625000
CY2023	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	516000
CY2024	egan	Schedule Of Accrued Compensation ScheduleOfAccruedCompensation	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:62.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:62.95%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:33.14%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of June 30,</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.95%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.61%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"> </p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14.61%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr style="height:0pt;visibility:hidden;"><td colspan="7" style="padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:62.95%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;"></span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:33.14%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(in thousands)</b></p></td></tr><tr><td style="vertical-align:bottom;width:62.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued bonuses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,007</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"> <span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,068</p></td></tr><tr><td style="vertical-align:bottom;width:62.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued vacation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,804</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"> <span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,715</p></td></tr><tr><td style="vertical-align:bottom;width:62.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Payroll and other employee related costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,325</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"> <span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,688</p></td></tr><tr><td style="vertical-align:bottom;width:62.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued commissions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 506</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> <span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 226</p></td></tr><tr><td style="vertical-align:bottom;width:62.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Accrued compensation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,642</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"> <span style="visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.94%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,697</p></td></tr></table>
CY2024Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3007000
CY2023Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3068000
CY2024Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	2804000
CY2023Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	2715000
CY2024Q2	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1325000
CY2023Q2	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1688000
CY2024Q2	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	506000
CY2023Q2	us-gaap	Accrued Liabilities For Commissions Expense And Taxes AccruedLiabilitiesForCommissionsExpenseAndTaxes	226000
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7642000
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7697000
CY2024Q2	egan	Value Added Tax Payable Current ValueAddedTaxPayableCurrent	920000
CY2023Q2	egan	Value Added Tax Payable Current ValueAddedTaxPayableCurrent	927000
CY2024Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	425000
CY2023Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1017000
CY2024Q2	egan	Customer Advances CustomerAdvances	132000
CY2023Q2	egan	Customer Advances CustomerAdvances	109000
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3601000
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3334000
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5078000
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5387000
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	92803000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98011000
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	92803000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98011000
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	92803000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98011000
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	45989000
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	47762000
CY2024Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	3280000
CY2023Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2101000
CY2024	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	36200000
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	38200000
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	78400000
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	60400000
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	18000000
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	6248000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-460000
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3470000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3816000
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	9718000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3356000
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2041000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	705000
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-632000
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1152000
CY2024	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	292000
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-559000
CY2024	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	599000
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	747000
CY2024	egan	Effective Income Tax Rate Reconciliation Foreign Withholding Tax EffectiveIncomeTaxRateReconciliationForeignWithholdingTax	23000
CY2023	egan	Effective Income Tax Rate Reconciliation Foreign Withholding Tax EffectiveIncomeTaxRateReconciliationForeignWithholdingTax	27000
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	410000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	136000
CY2024	egan	Effective Income Tax Rate Reconciliation Deferred Return To Provision Share Based Payment Arrangement Amount EffectiveIncomeTaxRateReconciliationDeferredReturnToProvisionShareBasedPaymentArrangementAmount	175000
CY2023	egan	Effective Income Tax Rate Reconciliation Deferred Return To Provision Share Based Payment Arrangement Amount EffectiveIncomeTaxRateReconciliationDeferredReturnToProvisionShareBasedPaymentArrangementAmount	284000
CY2024	egan	Effective Income Tax Rate Reconciliation Section267 Adjustment Amount EffectiveIncomeTaxRateReconciliationSection267AdjustmentAmount	1294000
CY2024	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	52000
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	118000
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1470000
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1726000
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	709000
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1938000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1247000
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	897000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	576000
CY2024	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	951000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1221000
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1848000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1797000
CY2024	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	90000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-550000
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	90000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-550000
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1938000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1247000
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	12000000.0
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	12300000
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3419000
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9115000
CY2024Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	10346000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	9404000
CY2024Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	15000
CY2024Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	853000
CY2023Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	898000
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4927000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	4500000
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1231000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1126000
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	443000
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent	563000
CY2024Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	4000
CY2024Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	178000
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	152000
CY2024Q2	egan	Deferred Tax Assets Accrued Payables Of Controlled Foreign Corporation DeferredTaxAssetsAccruedPayablesOfControlledForeignCorporation	1526000
CY2024Q2	egan	Deferred Tax Assets Capitalized Research And Development Costs DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts	14109000
CY2023Q2	egan	Deferred Tax Assets Capitalized Research And Development Costs DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts	10088000
CY2024Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	37051000
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	35846000
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35608000
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	34139000
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1443000
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1707000
CY2024Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	464000
CY2023Q2	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	601000
CY2024Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	5000
CY2023Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	42000
CY2024Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	469000
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	643000
CY2024	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1500000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1700000
CY2024Q2	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	26200000
CY2024	egan	Tax Cuts And Jobs Act Of2017 Global Intangible Low Taxed Income TaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncome	0
CY2023	egan	Tax Cuts And Jobs Act Of2017 Global Intangible Low Taxed Income TaxCutsAndJobsActOf2017GlobalIntangibleLowTaxedIncome	3400000
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1551000
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1556000
CY2024	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	161000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	130000
CY2024	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	71000
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	135000
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1641000
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1551000
CY2024Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	45000
CY2023Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0
CY2024Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2024	egan	Number Of Open Tax Years From Date Of Utilization Of Net Operating Loss Federal NumberOfOpenTaxYearsFromDateOfUtilizationOfNetOperatingLossFederal	3
CY2024	egan	Number Of Open Tax Years From Date Of Utilization Of Net Operating Loss State NumberOfOpenTaxYearsFromDateOfUtilizationOfNetOperatingLossState	4
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32698000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32268000
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29160000
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31482000
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4427011
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	185427
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	6524769
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4427011
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.10
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3116070
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M26D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4348562
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.09
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	3114689
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y8M15D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3366904
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	8.66
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3108203
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y3M10D
CY2024Q2	egan	Stock Option Intrinsic Value Closing Price StockOptionIntrinsicValueClosingPrice	6.31
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	806000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	866000
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4529000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6246000
CY2024	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	-97000
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	-117000
CY2024	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	4626000
CY2023	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	6363000
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.54
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.64
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0439
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0357
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y6M21D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y8M15D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2000000.0
CY2024	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y9M29D
CY2024	egan	Number Of Operating Leases Modified NumberOfOperatingLeasesModified	3
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2100000
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M7D
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0766
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0497
CY2024	us-gaap	Operating Lease Expense OperatingLeaseExpense	1345000
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	1284000
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1215000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1181000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1057000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	806000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	278000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	278000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1252000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4852000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1081000
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3771000
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1179000
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2592000
CY2024	egan	Warranty Period Maximum WarrantyPeriodMaximum	P1Y
CY2024Q2	egan	Stock Repurchase Program Increase In Authorized Amount StockRepurchaseProgramIncreaseInAuthorizedAmount	20000000
CY2024Q2	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	20000000
CY2024Q2	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	40000000
CY2024Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	17000000
CY2024	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	2751608
CY2024	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	6.28
CY2024	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	17300000
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24176000
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23815000
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22350000
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22462000
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	92803000
CY2023Q3	us-gaap	Gross Profit GrossProfit	17338000
CY2023Q4	us-gaap	Gross Profit GrossProfit	16825000
CY2024Q1	us-gaap	Gross Profit GrossProfit	15492000
CY2024Q2	us-gaap	Gross Profit GrossProfit	15556000
CY2024	us-gaap	Gross Profit GrossProfit	65211000
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1416000
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	2425000
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	938000
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1192000
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	5971000
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	2596000
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	2185000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1493000
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	1506000
CY2024	us-gaap	Net Income Loss NetIncomeLoss	7780000
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24763000
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25600000
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	23013000
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24635000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	98011000
CY2022Q3	us-gaap	Gross Profit GrossProfit	18481000
CY2022Q4	us-gaap	Gross Profit GrossProfit	18848000
CY2023Q1	us-gaap	Gross Profit GrossProfit	15418000
CY2023Q2	us-gaap	Gross Profit GrossProfit	17949000
CY2023	us-gaap	Gross Profit GrossProfit	70696000
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-670000
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	213000
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-512000
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2358000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	1389000
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-16000
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-104000
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-372000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	2601000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2109000
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001558370-24-012767-index-headers.html	Edgar Link	pending
0001558370-24-012767-index.html	Edgar Link	pending
0001558370-24-012767.txt	Edgar Link	pending
0001558370-24-012767-xbrl.zip	Edgar Link	pending
egan-20240630.xsd	Edgar Link	pending
egan-20240630x10k.htm	Edgar Link	pending
egan-20240630x10k005.jpg	Edgar Link	pending
egan-20240630xex21d1.htm	Edgar Link	pending
egan-20240630x10k_htm.xml	Edgar Link	completed
egan-20240630_cal.xml	Edgar Link	unprocessable
egan-20240630xex23d1.htm	Edgar Link	pending
egan-20240630xex31d1.htm	Edgar Link	pending
egan-20240630xex31d2.htm	Edgar Link	pending
egan-20240630xex32d1.htm	Edgar Link	pending
egan-20240630xex32d2.htm	Edgar Link	pending
egan-20240630xex97d1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
egan-20240630_def.xml	Edgar Link	unprocessable
egan-20240630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
egan-20240630_pre.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EGAN
eGain Corp Stock $egan

2024 Q3 Form 10-K Financial Statement

#000155837024012767 Filed on September 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EGAN eGain Corp Stock $egan

2024 Q3 Form 10-K Financial Statement

#000155837024012767 Filed on September 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EGAN
eGain Corp Stock $egan